APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,897,565 | -78.2% | 181,324 | -47.8% | 0.09% | -77.5% |
| Q2 2023 | $31,645,954 | +77.2% | 347,376 | +28.3% | 0.40% | +59.4% |
| Q1 2023 | $17,854,910 | +17.6% | 270,693 | -7.8% | 0.25% | +11.1% |
| Q4 2022 | $15,179,212 | -74.1% | 293,545 | -65.8% | 0.23% | -74.5% |
| Q3 2022 | $58,610,000 | +70.5% | 858,131 | +12.9% | 0.89% | +59.2% |
| Q2 2022 | $34,374,000 | +7.6% | 760,149 | +20.9% | 0.56% | +42.1% |
| Q1 2022 | $31,941,000 | +157.0% | 628,645 | +139.1% | 0.39% | +208.7% |
| Q4 2021 | $12,430,000 | +36.9% | 262,897 | -4.6% | 0.13% | +17.6% |
| Q3 2021 | $9,082,000 | -44.6% | 275,552 | +6.2% | 0.11% | -50.2% |
| Q2 2021 | $16,394,000 | +44.9% | 259,393 | -1.6% | 0.22% | +29.9% |
| Q1 2021 | $11,313,000 | -49.3% | 263,641 | -32.4% | 0.17% | -53.6% |
| Q4 2020 | $22,305,000 | +90.5% | 389,951 | +0.5% | 0.36% | +50.0% |
| Q3 2020 | $11,707,000 | -15.8% | 388,037 | -8.9% | 0.24% | -29.0% |
| Q2 2020 | $13,906,000 | +1.3% | 425,791 | -16.9% | 0.34% | -26.4% |
| Q1 2020 | $13,729,000 | -4.4% | 512,470 | -3.6% | 0.46% | +20.2% |
| Q4 2019 | $14,355,000 | +324.6% | 531,664 | +278.8% | 0.38% | +247.3% |
| Q3 2019 | $3,381,000 | – | 140,344 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |